Artal Group’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-500,000
Closed -$4.21M 121
2023
Q4
$4.21M Hold
500,000
0.14% 58
2023
Q3
$8.55M Hold
500,000
0.37% 45
2023
Q2
$11.6M Hold
500,000
0.36% 42
2023
Q1
$8.83M Sell
500,000
-200,000
-29% -$4.76M 0.52% 45
2022
Q4
$19M Sell
700,000
-200,000
-22% -$4.16M 1.06% 33
2022
Q3
$15.5M Hold
900,000
0.66% 31
2022
Q2
$15.7M Hold
900,000
0.84% 30
2022
Q1
$15.3M Hold
900,000
0.64% 36
2021
Q4
$24.4M Hold
900,000
0.66% 38
2021
Q3
$26.7M Hold
900,000
0.6% 40
2021
Q2
$34.6M Buy
900,000
+100,000
+13% +$3.42M 0.7% 31
2021
Q1
$24.4M Buy
800,000
+100,000
+14% +$3.74M 0.43% 52
2020
Q4
$26.7M Hold
700,000
0.57% 46
2020
Q3
$16.1M Sell
700,000
-50,000
-7% -$1.14M 0.39% 55
2020
Q2
$18.6M Buy
750,000
+150,000
+25% +$2.65M 0.52% 46
2020
Q1
$5.98M Hold
600,000
0.25% 68
2019
Q4
$8.61M Hold
600,000
0.33% 51
2019
Q3
$8.34M Hold
600,000
0.33% 56
2019
Q2
$8.8M Hold
600,000
0.36% 57
2019
Q1
$9.13M Buy
600,000
+150,000
+33% +$1.87M 0.37% 56
2018
Q4
$4.5M Hold
450,000
0.17% 70
2018
Q3
$7.25M Buy
+450,000
New +$7.89M 0.19% 64

Other funds holding REPL

Artal Group's REPL Position: Q1 2024 in Review

Artal Group sold out of Replimune Group (REPL) in Q1 2024, closing a stake of 500,000 shares — an estimated $4.21M sold.

Artal Group first reported a position in REPL in Q3 2018 and held it in 22 quarters. The position peaked at $34.6M in Q2 2021. 150 funds tracked by Wall St. Rank hold REPL as of Q1 2024.

  • Artal Group reported no remaining Replimune Group position as of Q1 2024 after selling out during the quarter.
  • Artal Group sold 500,000 Replimune Group shares in Q1 2024, an estimated $4.21M.
  • Artal Group first reported a position in Replimune Group in Q3 2018 and held it in 22 quarters.
  • Artal Group's Replimune Group position peaked at $34.6M in Q2 2021.
  • 150 funds tracked by Wall St. Rank held Replimune Group as of Q1 2024.

Based on Artal Group's 13F filing for Q1 2024, filed 13 May 2024.